Showing results (511-520 of 671) with videos related to
Sort By:
Pageof 68
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.Nature|September 30, 2016
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancerJimi Kim, Elizabeth McMillan, Hyun Seok Kim, et al.Cancer Research|December 4, 2012
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinomaPierre Saintigny, Erminia Massarelli, Steven Lin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune functionM Choi, H Kadara, J Zhang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.Nature Cancer|September 28, 2020
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancerShruthy Suresh, BeiBei Chen, Jingfei Zhu, et al.Cancers|July 9, 2022
Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) ComponentsRama Soundararajan, Paul Viscuse, Patrick Pilie, et al.Journal for Immunotherapy of Cancer|August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.Cancer|May 12, 2026
The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancerShetal A Patel, Jonathan L Heald, Michael Nead, et al.Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.Pageof 68